Skip to main content

Daptomycin Injection Shortage

Last Updated: August 29, 2022
Status: Resolved

Products Affected - Description
    • Daptomycin powder for solution for injection, Fresenius Kabi, 500 mg, vial, 1 count, NDC 63323-0871-15 - discontinued
    • Daptomycin powder for solution for injection, Fresenius Kabi, 500 mg, vial, 1 count, NDC 63323-0371-10 - discontinued
    • Daptomycin powder for solution for injection, Pfizer, 500 mg, vial, 1 count, NDC 00409-0106-01 - discontinued
Reason for the Shortage
    • BE Pharmaceuticals has daptomycin available.
    • Dr. Reddy's has daptomycin available.
    • Fresenius Kabi discontinued daptomycin in mid-2022.
    • Mylan Institutional has daptomycin available.
    • Pfizer discontinued daptomycin in December 2019.
    • Teva has daptomycin available.
    • Sagent had daptomycin on shortage due to manufacturing delays.
    • Merck has Cubicin and Cubicin RF available.
    • Xellia Pharmaceuticals has daptomycin available.
Available Products
    • Cubicin powder for solution for injection, Merck, 500 mg, vial, 1 count, NDC 67919-0011-01
    • Cubicin RF powder for solution for injection, Merck, 500 mg, vial, 1 count, NDC 67919-0012-01
    • Daptomycin powder for solution for injection, BE Pharmaceuticals, 500 mg, vial, 1 count, NDC 71839-0107-01
    • Daptomycin powder for solution for injection, Dr. Reddy's, 500 mg, vial, 1 count, NDC 43598-0413-11
    • Daptomycin powder for solution for injection, Mylan Institutional, 500 mg, vial, 1 count, NDC 67457-0813-50
    • Daptomycin powder for solution for injection, Sagent, 350 mg, vial, 1 count, NDC 25021-0179-15
    • Daptomycin powder for solution for injection, Sagent, 350 mg, vial, 10 count, NDC 25021-0179-16
    • Daptomycin powder for solution for injection, Teva, 500 mg, vial, 1 count, NDC 00703-0125-01
    • Daptomycin powder for solution for injection, Xellia Pharmaceuticals, 350 mg, vial, 1 count, NDC 70594-0053-01
    • Daptomycin powder for solution for injection, Xellia Pharmaceuticals, 500 mg, vial, 1 count, NDC 70594-0034-01

Estimated Resupply Dates

    • All marketed presentations are available.

Updated

Updated August 29, 2022 by Michelle Wheeler, PharmD, Drug Information Specialist. Created September 7, 2018 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2022, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.